
In the Bottom 40% of 2054 Similar Sized Companies on Comparably
In the Top 50% of 707 Nearby Companies in New York
2nd place versus 3 competitors rated on Comparably
Mr. Michael S. Weiss, also known as Mike, has been a Chairman of the Board of National Holdings Corporation in September 21, 2016. Mr. Weiss has served as Fortress Biotech Inc.'s (???Fortress???) Executive Vice Chairman, Strategic Development since January 2014 and has served as Co-Vice Chairman of Fortress's Board of Directors since December 2013. He served as President and Chief Executive Officer of Mustang Bio, Inc. He has been Chairman of Mustang Bio, Inc. since March 2015 and has been its Director since 2015. Since 2009, Mr. Weiss has served as Co-Portfolio Manager and Partner of Opus. In 2011, Mr. Weiss Co-Founded TG Therapeutics, Inc. (???TG???). Mr. Weiss serves as TG's Chairman, President and Chief Executive Officer. Prior to 2009, Mr. Weiss was Chairman and CEO of Keryx Biopharmaceuticals, Inc. Mr. Weiss began his professional career as a Lawyer with Cravath, Swaine & Moore LLP in NYC. Mr. Weiss earned his J.D. from Columbia Law School and his B.S. in Finance from The University at Albany.
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at TG Therapeutics.
Based on 15 ratings, Michael Weiss ranks right above Biogen's CEO, Michel Vounatsos.
TG Therapeutics' CEO is highly regarded by Female employees and Caucasian employees. Overall, the CEO score has remained stable over the last 90 days.
TG Therapeutics ranks in the Bottom 40% of other companies on Comparably with 11-50 Employees for CEO Rating Score.
TG Therapeutics ranks in the Top 50% of other companies in New York for CEO Rating Score.
